In the wake of hurricane-caused drug shortages, the American Hospital Association is calling on FDA to push manufacturers of small-volume parenteral solutions to invest in ways to prevent future shortages, including moving firms to areas not prone to natural disasters. The hospital trade group also wants FDA to loosen compounding restrictions in the event of shortage. Parenteral solutions were the first products FDA greenlighted for limited importation in the wake of manufacturing shortfalls due to hurricane damage in Puerto Rico...